drugset

drugset / Trial / NCT07492355

TP-3654 Food Effect Study

NCT07492355 ↗

Phase 1 Completed 24 enrolled Sumitomo Pharma America, Inc.

RandomizedSequentialOpen-labelOther

Summary

This clinical trial will determine the bioavailability and effect of food on TP-3654 in healthy adult participants.

Timeline

Start: 2024-03-04
Primary completion: 2024-05-31
Completion: 2024-05-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	NUVISERTIB	Small molecule	—	Oral

Indications